Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer

By Moon Yong   Jeung Hei-Cheul   Rha Sun   Choi Yeon   Yang Woo   Chung Hyun  

Breast Cancer Research and Treatment, Vol. 104, Iss. 1, 2007-07 ,pp. : 31-37

Springer Publishing Company

Access to resources Recommend Favorite

Sexual Functioning in Long-Term Breast Cancer Survivors Treated with Adjuvant Chemotherapy

By Broeckel J.A.  

Breast Cancer Research and Treatment, Vol. 75, Iss. 3, 2002-10 ,pp. : 241-248

Springer Publishing Company

Access to resources Recommend Favorite

FHIT alterations in breast cancer

By Ingvarsson S.  

Seminars in Cancer Biology, Vol. 11, Iss. 5, 2001-10 ,pp. : 361-366

Academic Press

Access to resources Recommend Favorite

Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer

By Appel Jon M.   Zerahn Bo   Møller Susanne   Christensen Heidi M.   Søgaard Peter   Ejlertsen Bent   Fogh-Andersen Niels   Jensen Benny V.   Nielsen Dorte L.  

Acta Oncologica, Vol. 51, Iss. 8, 2012-11 ,pp. : 1054-1061

Informa Healthcare

Access to resources Recommend Favorite

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy

By Silverman Daniel   Dy Christine   Castellon Steven   Lai Jasmine   Pio Betty   Abraham Laura   Waddell Kari   Petersen Laura   Phelps Michael   Ganz Patricia  

Breast Cancer Research and Treatment, Vol. 103, Iss. 3, 2007-07 ,pp. : 303-311

Springer Publishing Company

Access to resources Recommend Favorite